Phylogica to Offer Peptide Candidates Delivered with Aegis’ Nasal Spray Technology
Firm has a library of peptides sourced from nonhuman biological genomes. Phylogica plans on using Aegis Therapeutics’ Intravail® transmucosal delivery formulations with its peptide drug candidates. The compani…
Read guide →